Table 1.
Summary of the study groups.
| n | Gender (male/ female) | Mean age | Positive screening confirmed w/Luminex (male/female) | Neg scr Pre-Covid (deferred) | Same antibody pattern post/pre | |
|---|---|---|---|---|---|---|
| Moderna | 32 | 15/17 | 52 | 6 (2/4) | 2 | Yes |
| Pfizer | 26 | 10/16 | 50 | 1 (female) | 0 | |
| Astra-Zeneca | 40 | 7/33 | 33 | 5 (1/4) | 1a | Yes |
| Covid + vaccine(s) | 8 | 4/4 | 41 | 0 | ||
| CCP donors with pos. anti-HLA screening | 11 | 4/7 | 51 | 9b | 0 | Yes |
a
one new donor without pre-Covid sample was also deferred
b
two donors concluded as negative following specificity assay (Luminex), returned to donation